Skip to main content
89°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ASND
Recent news which mentions ASND
< Previous
1
2
3
4
5
Next >
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
September 24, 2024
Tickers
ASND
NEWS
Tags
Benzinga
News
Trading Ideas
From
Benzinga
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Tickers
ASND
BHC
BLCO
EWTX
Tags
Stories That Matter
Benzinga
Top Stories
From
Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Tickers
AJG
ASND
BMRN
BNTX
Tags
AJG
Benzinga
RIVN
From
Benzinga
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term
September 16, 2024
Tickers
ASND
BMRN
NEWS
Tags
ASND
News
Analyst Color
From
Benzinga
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
September 16, 2024
Tickers
ASND
ITOS
NCNA
NEWS
Tags
Equities
Market News
NUVL
From
Benzinga
Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
September 16, 2024
Tickers
ASND
NEWS
Tags
why it's moving
General
Benzinga
From
Benzinga
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
September 16, 2024
Tickers
AA
ASND
BLCO
CRVS
Tags
JBDI
big gainers
AA
From
Benzinga
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
September 04, 2024
Tickers
ASND
BMRN
NEWS
NVO
Tags
Analyst Color
PFE
Trading Ideas
From
Benzinga
Why Ascendis Pharma Stock Tumbled by 11% Today
September 04, 2024
Tickers
ASND
Tags
Market News
ASND
Recent Press Releases
From
Motley Fool
Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance Cut
September 04, 2024
Tickers
ASND
NEWS
RPRX
Tags
why it's moving
General
Benzinga
From
Benzinga
Core & Main Reports Downbeat Results, Joins Rev Group, PagerDuty, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 04, 2024
Tickers
ASAN
ASND
CNM
CRMT
Tags
DLTR
Premarket
big losers
From
Benzinga
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
August 13, 2024
Tickers
AILE
ASND
CLNE
CLVT
Tags
HSAI
PEN
SPRY
From
Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
August 12, 2024
Tickers
ASND
NEWS
TAK
Tags
TAK
General
why it's moving
From
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $5,900 Today
August 09, 2024
Tickers
ASND
NEWS
Tags
Benzinga
ASND
News
From
Benzinga
$1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
July 18, 2024
Tickers
ASND
NEWS
Tags
Market News
BZI/POD
ASND
From
Benzinga
Macy's, Ascendis Pharma And 3 Stocks To Watch Heading Into Friday
July 05, 2024
Tickers
ASND
ERIC
GFL
LGIH
Tags
M
LGIH
News
From
Benzinga
Here's How Much $1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
July 03, 2024
Tickers
ASND
NEWS
Tags
Market News
BZI/POD
Trading Ideas
From
Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 15 Years
June 26, 2024
Tickers
ASND
NEWS
Tags
Benzinga
ASND
Trading Ideas
From
Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $4,100 Today
May 31, 2024
Tickers
ASND
NEWS
Tags
Benzinga
ASND
Trading Ideas
From
Benzinga
(ASND) - Analyzing Ascendis Pharma's Short Interest
May 28, 2024
Tickers
ASND
Tags
Short Ideas
Benzinga
Short Sellers
From
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $6,500 Today
May 17, 2024
Tickers
ASND
NEWS
Tags
Market News
BZI/POD
ASND
From
Benzinga
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
May 15, 2024
Tickers
ASND
NEWS
Tags
Benzinga
Health Care
General
From
Benzinga
$100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
May 06, 2024
Tickers
ASND
NEWS
Tags
Market News
BZI/POD
News
From
Benzinga
ASND Stock Earnings: Ascendis Pharma Reported Results for Q1 2024
May 02, 2024
Tickers
ASND
Tags
Market News
NASDAQ:ASND
ASND
From
InvestorPlace
Looking Into Ascendis Pharma's Recent Short Interest
April 26, 2024
Tickers
ASND
Tags
BZI/SHORTHIST
Market News
Trading Ideas
From
Benzinga
$1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
April 18, 2024
Tickers
ASND
NEWS
Tags
BZI/POD
Market News
Benzinga
From
Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
April 03, 2024
Tickers
ASND
NEWS
Tags
Market News
BZI/POD
Trading Ideas
From
Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
March 14, 2024
Tickers
ASND
NEWS
Tags
Benzinga
News
Trading Ideas
From
Benzinga
These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher
March 03, 2024
Tickers
AAPL
AMZN
ASND
FIX
Tags
Market News
Politics
Markets
From
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
February 23, 2024
Tickers
ASND
NEWS
Tags
Benzinga
News
Trading Ideas
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
